SUMMARY
blood pressure, the renal vasculature may play a more important role in both pressor and depressor aspects in the regulation of blood pressure as compared to its role in norepinephrine-induced hypertension.
Additional
Indexing Words: Norepinephrine Angiotensin II Renal blood flow Renal nerve denervation INCE under normal conditions the two kidneys receive 15 to 25% of the cardiac output,1) the renal vascular resistance influences the total peripheral resistance.
In this respect, the renal vasculature has been considered to be, in addition to vasoactive hormones and the water and sodium balance one of the important renal factors in the regulation of blood pressure.2) Among antihypertensive agents, calcium antagonists, which are potent vasodilators, have been reported to exert various actions on renal function and hemodynamics.3)-5)
Numerous investigations have examined the effects of calcium antagonists on blood pressure and renal function in both physiological and pathological conditions.6)-12) However, there have been few papers dealing with the direct actions of calcium antagonists on the renal vasculature in pathological conditions.
It is of interest therefore to examine their direct effects on the renal vasculature through the intrarenal administration of a calcium antagonist to rabbits with acutely elevated blood pressure induced by two vasoactive agents, norepinephrine and angiotensin II.
METHODS
Experiments were carried out on female Japanese white rabbits weighing between 2.4 and 3.3kg.
The animals were maintained on a normal chow diet and tap water ad libitum for 7 days. Twelve hours before the experiments, food was withheld but water was allowed ad libitum. Anesthesia was induced with intravenous pentobarbital sodium (30mg/kg), and maintenance doses of the anesthetic given as needed.
Two polyethylene catheters (Intramedic, Clay Adams, New Jersey, USA) were placed in the femoral artery (PE 90) for recording the mean arterial pressure and heart rate and in the femoral vein (PE 20) for infusion of agents. In half of the animals, a PE 20 catheter was inserted into the opposite femoral vein, and the remaining animals were prepared for insertion of a renal catheter. Implantation of the renal catheter was performed in a similar manner to that described by Smits et al13) with some modifications.
Briefly, following midline laparotomy, the left renal artery and suprarenal artery were located. the intrarenal injection of nicardipine on mean arterial pressure and renal blood flow as compared to intravenous injection of nicardipine (Fig.2) . In angiotensin II-induced elevation of blood pressure, the fall in mean arterial pressure was significantly correlated with the change in renal blood flow after intrarenal injection of nicardipine to animals without renal nerve denervation (r=-0.68, p<0.05, n=12).
DISCUSSION
Both intrarenal and intravenous injection of nicardipine reduced the blood pressure in conscious unrestrained rabbits with norepinephrine-and angiotensin II-induced elevation of blood pressure, but not that of normotensive controls. The depressor effect of intrarenal injection of nicardipine on the elevated blood pressure was greater than that of intravenous injection following angiotensin II-but not norepinephrine-infusion. This action is mainly followed by restoration of renal blood flow. In addition, renal denervation abolished the greater depressor effect of intrarenal injection of nicardipine in angiotensin II-induced elevation of blood pressure. Studies of the effects of calcium antagonists on norepinephrine-induced vasoconstriction have shown conflicting results.8)-14) Some investigators have reported that calcium antagonists reverse norepinephrine-induced vasoconstriction,12) whereas others failed to demonstrate such a reversal.9) Since the discrepancies may arise from different experimental conditions, such as the choice of conscious or anesthetized animals, the type of animals employed and the calcium antagonists administered, it is difficult to compare and evaluate all the previously reported data. In the present study, we employed conscious unrestrained rabbits which received nicardipine.
It is generally agreed that calcium antagonists reduce blood pressure through their potent vasodilating action, although intrarenal hemodynamic actions have been proposed as one of the other possible antihypertensive mechanisms.15)-19) Following norepinephrine-infusion, the depressor effects of intrarenal and intravenous administration of nicardipine were not significantly different.
Further, after renal denervation, there were no significant differences in blood pressure, heart rate and renal blood flow between these two routes of administration. Therefore, in so far as the antihypertensive effects of nicardipine on norepinephrine-induced elevation of blood pressure are concerned, the renal vasculature does not seem to play a major role.
In contrast to the conflicting data for the effects on norepinephrineinduced vasoconstriction, in all studies in which exogenous angiotensin II was administered, calcium antagonists increased the renal blood flow and GFR.5)-7) Our findings are in good agreement with these previous results. Further, both intrarenal and intravenous administration of nicardipine significantly increased the suppressed renal blood flow in angiotensin II-induced elevation of blood pressure compared to that following norepineprine-infusion. These results may be due to the different mechanisms of vasoconstriction between norepinephrine and angiotensin II.9),16)
In comparison with the effects of norepinephrine on renal blood flow, angiotensin II revealed a more potent vasoconstricting action on the renal vasculature, since at the same levels of elevated blood pressure, the renal blood flow was significantly reduced in angiotensin II-induced elevation of blood pressure. These findings are similar to the report of Goldberg and Schrier.12) The depressor effects of calcium antagonists on angiotensin IIinduced elevation of blood pressure were greater with intrarenal administration than with intravenous administration.
Further, the degree of fall in blood pressure in angiotensin II-infusion was significantly correlated with the Jpn. Heart J. M ay 1987 changes in renal blood flow after intrarenal injection of nicardipine. These findings suggest therefore that vasodilation of the renal vascular bed contributes to the depressor action of nicardipine in angiotensin II-induced hypertension.
As was the case in norepinephrine-induced elevation of blood pressure, after renal nerve denervation there were no significant differences in changes of blood pressure between intrarenal and intravenous administration of nicardipine in spite of the same degree of reduction in renal blood flow. This implies that in the renal vasculature the resistance vessels may be strongly regulated by the renal sympathetic tone. Guo and Abboud20) have demonstrated that angiotensin II impairs reflex decreases in heart rate and lumbar sympathetic nerve activity during hypertension but not reflex increases in them during hypotension. Furthermore, Clapham16) has demonstrated that the ability of nifedipine to inhibit pressor responses to neuronally released norepinephrine, as well as pressor responses to angiotensin II, contributes to the efficacy of this drug as an antihypertensive in SHR. In these respects, the interaction between the sympathetic nervous system and angiotensin II in the renal vasculature may be more important for the control of the vascular tone in the regulation of blood pressure than has previously been considered.
However, before any final conclusion can be drawn, further investigations are needed of the complex relationships and individual roles in the regulation of blood pressure among the baroreceptors, sympathetic nervous system, and renin-angiotensin system as well as the antihypertensive actions of calcium antagonists on the kidney.
In summary, the calcium antagonist, nicardipine, was shown to reduce the acutely elevated blood pressure caused by norepinephrine and angiotensin II. In angiotensin II-induced hypertension, the renal vasculature may play a more important role in the regulation of blood pressure in both pressor and depressor aspects as compared to its role in norepinephrine-induced hypertension. 
